BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30242938)

  • 1. Mechanisms shaping the mutational landscape of the FRA3B/FHIT-deficient cancer genome.
    Saldivar JC; Park D
    Genes Chromosomes Cancer; 2019 May; 58(5):317-323. PubMed ID: 30242938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of genome instability and preneoplastic processes through loss of Fhit expression.
    Saldivar JC; Miuma S; Bene J; Hosseini SA; Shibata H; Sun J; Wheeler LJ; Mathews CK; Huebner K
    PLoS Genet; 2012; 8(11):e1003077. PubMed ID: 23209436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile Genes That Are Frequently Altered in Cancer: Players Not Passengers.
    Karras JR; Schrock MS; Batar B; Huebner K
    Cytogenet Genome Res; 2016; 150(3-4):208-216. PubMed ID: 28199992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.
    Hosseini SA; Horton S; Saldivar JC; Miuma S; Stampfer MR; Heerema NA; Huebner K
    Genes Chromosomes Cancer; 2013 Nov; 52(11):1017-29. PubMed ID: 23929738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
    Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
    Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
    Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
    Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
    Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication stress induces tumor-like microdeletions in FHIT/FRA3B.
    Durkin SG; Ragland RL; Arlt MF; Mulle JG; Warren ST; Glover TW
    Proc Natl Acad Sci U S A; 2008 Jan; 105(1):246-51. PubMed ID: 18162546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FHIT gene product: tumor suppressor and genome "caretaker".
    Waters CE; Saldivar JC; Hosseini SA; Huebner K
    Cell Mol Life Sci; 2014 Dec; 71(23):4577-87. PubMed ID: 25283145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of
    Simón-Carrasco L; Pietrini E; López-Contreras AJ
    Cell Cycle; 2024 Jan; 23(1):92-113. PubMed ID: 38234243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of deletions at the FRA3B/FHIT locus in carcinogenesis.
    Huebner K; Druck T; Siprashvili Z; Croce CM; Kovatich A; McCue PA
    Recent Results Cancer Res; 1998; 154():200-15. PubMed ID: 10027001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fhit deficiency-induced global genome instability promotes mutation and clonal expansion.
    Miuma S; Saldivar JC; Karras JR; Waters CE; Paisie CA; Wang Y; Jin V; Sun J; Druck T; Zhang J; Huebner K
    PLoS One; 2013; 8(11):e80730. PubMed ID: 24244712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fhit loss-associated initiation and progression of neoplasia in vitro.
    Karras JR; Schrock MS; Batar B; Zhang J; La Perle K; Druck T; Huebner K
    Cancer Sci; 2016 Nov; 107(11):1590-1598. PubMed ID: 27513973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitous 'cancer mutational signature' 5 occurs specifically in cancers with deleted
    Volinia S; Druck T; Paisie CA; Schrock MS; Huebner K
    Oncotarget; 2017 Nov; 8(60):102199-102211. PubMed ID: 29254236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
    Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV
    Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genomic mapping of the bovine Fragile Histidine Triad (FHIT) tumour suppressor gene: characterization of a 2 Mb BAC contig covering the locus, complete annotation of the gene, analysis of cDNA and of physiological expression profiles.
    Uboldi C; Guidi E; Roperto S; Russo V; Roperto F; Di Meo GP; Iannuzzi L; Floriot S; Boussaha M; Eggen A; Ferretti L
    BMC Genomics; 2006 May; 7():123. PubMed ID: 16719907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic instability of the tumor suppressor gene FHIT in normal human cells.
    Palumbo E; Tosoni E; Matricardi L; Russo A
    Genes Chromosomes Cancer; 2013 Sep; 52(9):832-44. PubMed ID: 23780737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common fragile sites, extremely large genes, neural development and cancer.
    Smith DI; Zhu Y; McAvoy S; Kuhn R
    Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers.
    Turner BC; Ottey M; Zimonjic DB; Potoczek M; Hauck WW; Pequignot E; Keck-Waggoner CL; Sevignani C; Aldaz CM; McCue PA; Palazzo J; Huebner K; Popescu NC
    Cancer Res; 2002 Jul; 62(14):4054-60. PubMed ID: 12124341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach to simultaneously scan genes at fragile sites.
    Willem P; Brown J; Schouten J
    BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.